Professor of Obstetrics & Gynecology, Chair of Maternal-Fetal Medicine Division, Director of the Mayo Clinic Fetal Diagnostic & Therapeutic Center
Mayo Clinic, Rochester, MN
Rochester, Minnesota, United States
Rodrigo Ruano, M.D., Ph.D. is a Professor of Obstetrics, Gynecology and Reproductive Sciences at University of Miami Miller School of Medical, Chief of Maternal-Fetal Medicine Division, Director of the UHealth Jackson Fetal Care and Co-Director of the Labor & Delivery Service at UM Health-Jackson Hospital in Miami, Florida since January 2022.
He received his medical degree from the Medical School of University of São Paulo, São Paulo, Brazil (1992-1997). He completed his residency at the Hospital das Clinicas Medical School of University of São Paulo, São Paulo, Brazil (1998-2001). Additional training included a Maternal-Fetal Medicine fellowship at Hôpital Necker-Enfants Malades, AP-HP, Université de Paris V, Paris, France (2001-2003) and Fetal Surgery fellowship at Centre Hospitalier Intercommunal Saint-Germain-en-Laye, Université de Versailles Saint-Quentin-em-Yvelines, France (2003-2004). He concluded his PhD thesis “Evaluation of lung volumes by 3D-ultrasonography in fetuses with diaphragmatic hernia congenital isolation” at the Medical School of University of São Paulo, São Paulo, Brazil in 2005. He was Professor of Obstetrics and Gynecology, Pediatrics and Physiology, Chair of Maternal-Fetal Medicine Division and Director of Fetal Section at Mayo Clinic Rochester from 2016-2021. Before he was Professor of Obstetrics and Gynecology at Baylor College of Medicine and Co-Director of the Texas Children’s Fetal Center in Houston, Texas, from 2011 to 2016; and Professor of Obstetrics and Gynecology at University of Sao Paulo, Brazil between 2006 and 2010.
Dr. Ruano has authored over 250 peer-reviewed articles (PUBMED) and 50 book chapters pertaining to maternal-fetal medicine, prenatal detection of congenital anomalies, 3D/4D fetal ultrasonography, and fetal surgery.
Dr. Ruano focuses his clinical efforts on developing and investigating new minimally invasive fetal therapies such as fetal endoscopic tracheal occlusion (FETO) for congenital diaphragmatic hernia, fetal cystoscopy for fetal bladder obstruction, in utero repair of fetal spina bifida and fetoscopic laser ablation for twin-twin transfusion syndrome.
Tuesday, March 28, 2023
1:30 PM – 3:00 PM